Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-2-methyl-1-ethanol
2. 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidineethanol
3. 61 91 Rc
4. Alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine Ethanol
5. Ifenprodil
6. Ifenprodil Hydrochloride
7. Ifenprodil Hydrochloride, (+-)-isomer
8. Ifenprodil Tartrate (1:1), (r*,s*)-(+-)-(r-(r*,r*))-isomer
9. Ifenprodil Tartrate (1:1), (r-(r*,r*))-isomer
10. Ifenprodil Tartrate (2:1), (r-(r*,r*))-isomer
11. Ifenprodil, (r*,s*)-(+-)-isomer
12. Ifenprodil, Tartrate(r-(r*,r*))-isomer
13. Vadilex
1. Ifenprodil Tartrate Salt
2. 23210-58-4
3. Ifenprodil Hemitartrate
4. Prestwick_623
5. 2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-1-propanol Hemitartrate
6. Prestwick0_000311
7. Prestwick1_000311
8. Prestwick2_000311
9. Prestwick3_000311
10. Lopac0_000661
11. Bspbio_000302
12. Mls000069744
13. Schembl364019
14. Spbio_002521
15. Bpbio1_000334
16. Chembl1256662
17. Hms1568p04
18. Hms2095p04
19. Hms2231m13
20. Hms3369e02
21. Hms3712p04
22. Ccg-220311
23. Ac-33093
24. Smr000058797
25. 210i584
26. Http://www.dcchemicals.com/product_show-dc23902.html
27. Sr-01000075169-10
28. 4-[(1r*,2s*)-2-(4-benzyl-piperidin-1-yl)-1-hydroxy-propyl]-pheno
29. 4-(2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl)phenol 2,3-dihydroxysuccinate
30. 4-[2-(4-benzyl-1-piperidyl)-1-hydroxy-propyl]phenol; 2,3-dihydroxybutanedioic Acid
31. 1-piperidineethanol, .alpha.-(4-hydroxyphenyl)-.beta.-methyl-4-(phenylmethyl)-, 2,3-dihydroxybutanedioate (1:1) (salt)
Molecular Weight | 475.5 g/mol |
---|---|
Molecular Formula | C25H33NO8 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 8 |
Exact Mass | 475.22061701 g/mol |
Monoisotopic Mass | 475.22061701 g/mol |
Topological Polar Surface Area | 159 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 487 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 4 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Excitatory Amino Acid Antagonists
Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?